KR102543302B1 - Cosmetic composition for skin whitening and manufacturing method thereof - Google Patents
Cosmetic composition for skin whitening and manufacturing method thereof Download PDFInfo
- Publication number
- KR102543302B1 KR102543302B1 KR1020230038444A KR20230038444A KR102543302B1 KR 102543302 B1 KR102543302 B1 KR 102543302B1 KR 1020230038444 A KR1020230038444 A KR 1020230038444A KR 20230038444 A KR20230038444 A KR 20230038444A KR 102543302 B1 KR102543302 B1 KR 102543302B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- extract
- skin
- cosmetic composition
- skin whitening
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 90
- 239000002537 cosmetic Substances 0.000 title claims abstract description 72
- 230000002087 whitening effect Effects 0.000 title claims abstract description 50
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 75
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 26
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 239000009724 Salvia extract Substances 0.000 claims abstract description 13
- 235000011187 glycerol Nutrition 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 12
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims abstract description 11
- 239000008213 purified water Substances 0.000 claims abstract description 10
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- -1 Bioflavonoids Substances 0.000 claims description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 14
- 244000157072 Hylocereus undatus Species 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 11
- 235000018481 Hylocereus undatus Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 11
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 11
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 9
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 9
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 9
- 235000019192 riboflavin Nutrition 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 239000002151 riboflavin Substances 0.000 claims description 9
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 8
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 8
- 229960005070 ascorbic acid Drugs 0.000 claims description 8
- 235000010323 ascorbic acid Nutrition 0.000 claims description 8
- 239000011668 ascorbic acid Substances 0.000 claims description 8
- 229960001631 carbomer Drugs 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 230000003750 conditioning effect Effects 0.000 claims description 8
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 8
- 229960003966 nicotinamide Drugs 0.000 claims description 8
- 235000005152 nicotinamide Nutrition 0.000 claims description 8
- 239000011570 nicotinamide Substances 0.000 claims description 8
- 229940101267 panthenol Drugs 0.000 claims description 8
- 235000020957 pantothenol Nutrition 0.000 claims description 8
- 239000011619 pantothenol Substances 0.000 claims description 8
- 235000008160 pyridoxine Nutrition 0.000 claims description 8
- 239000011677 pyridoxine Substances 0.000 claims description 8
- 229940011671 vitamin b6 Drugs 0.000 claims description 8
- 229940093797 bioflavonoids Drugs 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 229960002104 cyanocobalamin Drugs 0.000 claims description 7
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 7
- 239000011666 cyanocobalamin Substances 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 239000003708 ampul Substances 0.000 claims description 6
- 229960000401 tranexamic acid Drugs 0.000 claims description 6
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 239000006260 foam Substances 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 235000012711 vitamin K3 Nutrition 0.000 claims description 4
- 239000011652 vitamin K3 Substances 0.000 claims description 4
- 229940041603 vitamin k 3 Drugs 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 244000082988 Secale cereale Species 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 abstract description 18
- 239000003963 antioxidant agent Substances 0.000 abstract description 13
- 230000003078 antioxidant effect Effects 0.000 abstract description 13
- 230000032683 aging Effects 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 8
- 235000013599 spices Nutrition 0.000 abstract description 6
- 230000037303 wrinkles Effects 0.000 abstract description 5
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 abstract description 2
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 abstract description 2
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 abstract description 2
- 229940117895 bakuchiol Drugs 0.000 abstract description 2
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 abstract description 2
- 235000001715 Lentinula edodes Nutrition 0.000 abstract 1
- 230000037319 collagen production Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 93
- 230000000694 effects Effects 0.000 description 24
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 238000009472 formulation Methods 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 241000209056 Secale Species 0.000 description 11
- 235000007238 Secale cereale Nutrition 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 206010040880 Skin irritation Diseases 0.000 description 10
- 230000036556 skin irritation Effects 0.000 description 10
- 231100000475 skin irritation Toxicity 0.000 description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229940008099 dimethicone Drugs 0.000 description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 229920002674 hyaluronan Polymers 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 108010024636 Glutathione Proteins 0.000 description 7
- 241000229143 Hippophae Species 0.000 description 7
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 7
- 239000002738 chelating agent Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229960003180 glutathione Drugs 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 230000009759 skin aging Effects 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 229920006037 cross link polymer Polymers 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000036560 skin regeneration Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- 229920002554 vinyl polymer Polymers 0.000 description 5
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 3
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 229940074979 cetyl palmitate Drugs 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000003810 hyperpigmentation Effects 0.000 description 3
- 208000000069 hyperpigmentation Diseases 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 229950003429 sorbitan palmitate Drugs 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 2
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000037373 wrinkle formation Effects 0.000 description 2
- XADJANKGURNTIA-YEXRKOARSA-N (2r)-2-[(3s,5r,10s,13r,14r,16r,17r)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)[C@H](O)C[C@]21C XADJANKGURNTIA-YEXRKOARSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- UGMQOYZVOPASJF-UHFFFAOYSA-N Eburicoinsaeure Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC21C UGMQOYZVOPASJF-UHFFFAOYSA-N 0.000 description 1
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 description 1
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- XADJANKGURNTIA-UHFFFAOYSA-N Tumulosic acid Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C XADJANKGURNTIA-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 230000007691 collagen metabolic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 피부 미백용 화장료 조성물 및 그 제조방법에 관한 것으로서, 보다 상세하게는, 우수한 항산화 및 항염증 활성을 나타낼 뿐만 아니라, 자외선 등 외부 자극으로부터 손상된 피부를 보호함으로써 피부 미백 효과를 나타내고, 콜라겐의 생성을 촉진하여 피부 주름 형성 및 노화를 방지할 수 있는, 피부 미백용 화장료 조성물 및 상기 화장료 조성물의 제조방법에 관한 것이다.The present invention relates to a cosmetic composition for skin whitening and a method for producing the same, and more specifically, exhibits excellent antioxidant and anti-inflammatory activity, and exhibits a skin whitening effect by protecting damaged skin from external stimuli such as ultraviolet rays, It relates to a cosmetic composition for skin whitening, which can prevent skin wrinkle formation and aging by promoting generation, and a method for manufacturing the cosmetic composition.
의술의 발달로 평균수명이 연장됨에 따라 가능한 젊음을 길게 유지하고자 하는 욕구는 남녀노소의 공통 관심사가 되었으며 가장 쉽게 드러나는 피부 노화 방지에 대한 열망이 높아지고 있다. 이에 따라, 피부 노화의 발생 원인을 찾고 이를 억제할 수 있는 소재 개발 연구가 활발히 이어지고 있다. 피부 노화는 원인에 따라 크게 세 가지로 구분된다. As the average lifespan has been extended due to the development of medical technology, the desire to maintain youth as long as possible has become a common concern for men and women of all ages, and the desire to prevent skin aging, which is most easily revealed, is increasing. Accordingly, research on the development of materials capable of finding the cause of skin aging and suppressing it is being actively conducted. Skin aging is divided into three main categories depending on the cause.
첫 번째는 자연 노화(Intrinsic aging)로, 나이가 듦에 따라 생체 면역체계 및 생리활성 기능이 떨어져 히알루론산, 콜라겐 등 피부 구성요소를 원활히 회복하지 못하여 피부의 탄력이 감소되고 건조 현상이 일어나 잔주름 등이 형성된다. 히알루론산은 세포외기질 성분 중의 하나로 건조 중량으로는 불과 0.1 내지 0.2%를 차지하고 있지만 진피의 타 구성성분들과 그물망을 이루어 세포를 서로 연결하고 영양분을 전달하는 역할을 담당하며 피부의 수분 증발을 막는 동시에 물 분자와의 강력한 결합으로 피부가 일정한 양의 수분을 유지할 수 있도록 한다. 피부 내 히알루론산의 감소는 18세 내지 20 세부터 시작하여 나이가 듦에 따라 또는 환경오염이나 자외선 노출에 의해 분해가 가속화 되어 진피 내 히알루론산의 감소는 피부탄력 저하, 주름 생성 및 건조 피부의 원인이 되기도 한다. 이러한 이유로 나이가 들어감에 따라 감소한 피부 내 히알루론산을 보충하여 노화를 예방하고자 하는 접근이 이루어져 왔다. 또한, 콜라겐은 진피 전체의 70 내지 80%를 차지하고 있어 콜라겐의 분해는 피부 내 탄력 감소, 피부 미백, 및 주름 형성과 밀접히 관련되어 있다. The first is natural aging (intrinsic aging). As the body ages, the body's immune system and physiological activity decline, preventing smooth recovery of skin components such as hyaluronic acid and collagen, resulting in reduced skin elasticity and dryness, resulting in fine wrinkles, etc. is formed Hyaluronic acid is one of the components of the extracellular matrix and accounts for only 0.1 to 0.2% in terms of dry weight, but forms a network with other components of the dermis to connect cells to each other, deliver nutrients, and prevent evaporation of moisture from the skin. At the same time, strong bonding with water molecules enables the skin to maintain a certain amount of moisture. The decrease of hyaluronic acid in the skin starts from the age of 18 to 20, and decomposition is accelerated with aging or by environmental pollution or exposure to ultraviolet rays. it can also be For this reason, approaches have been made to prevent aging by supplementing hyaluronic acid in the skin, which is reduced with age. In addition, since collagen accounts for 70 to 80% of the entire dermis, degradation of collagen is closely related to reduction of skin elasticity, skin whitening, and wrinkle formation.
두 번째로는, 외인성 노화(Extrinsic aging)라 하여 자외선 등 외부 스트레스로 인해 발생하는 노화이다. 자외선은 체내에서 비타민 D를 합성하고, 살균 작용의 역할이 있으나, 피부염, 피부암, 일광 화상, 피부노화, 건조, 잔주름 등을 생기게도 한다. 자외선(Ultraviolet, UV)은 파장 길이에 따라 A, B, C의 3가지로 나뉘는데, 이 중 UVC는 오존층에서 차단되고 UVA와 UVB가 피부에 영향을 미친다.Second, extrinsic aging is aging caused by external stress such as ultraviolet rays. Ultraviolet rays synthesize vitamin D in the body and have a role in sterilization, but also cause dermatitis, skin cancer, sunburn, skin aging, dryness, and fine wrinkles. Ultraviolet (UV) is divided into three types, A, B, and C, depending on the wavelength. Among them, UVC is blocked by the ozone layer, and UVA and UVB affect the skin.
특히, 중간 파장인 UVB(290~320nm)는 급성이나 만성적으로 노출되었을 경우, 피부를 검게 만들 뿐만 아니라 심각한 피부 손상을 야기하는데, 피부 진피 내 구성성분인 콜라겐(collagen), 엘라스틴(elastin), 히알루론산(hyaluronic acid) 등을 파괴하여 피부의 탄력 소실을 유도하고 그 결과 굵은 주름이 생성된다. 또한, 자외선에 의해 생성되는 활성산소는 세포내 신호전달 체계를 손상시켜 피부에서 콜라겐(collagen) 분해효소인 MMP-1(Matrix metalloproteinase-1)의 발현을 증가시켜 콜라겐을 파괴한다.In particular, when acutely or chronically exposed to medium-wavelength UVB (290-320 nm), it not only blackens the skin but also causes serious skin damage. It destroys hyaluronic acid, etc., and induces loss of skin elasticity, resulting in thick wrinkles. In addition, active oxygen generated by ultraviolet rays damages the intracellular signal transduction system and destroys collagen by increasing the expression of matrix metalloproteinase-1 (MMP-1), a collagen degrading enzyme in the skin.
세 번째는, 피부 세포의 손상을 유발하는 활성산소를 들 수 있다. 활성산소는 지나치게 많아질 경우 체내의 항산화 방어계를 무너뜨려 단백질, 지질, DNA와 같은 세포 성분을 손상시키고, 이에 따라 세포 기능이 변질되어 궁극적으로 피부 노화가 촉진될 수 있다. 또한, 활성산소는 교원질 대사에 작용하여 직접적으로 교원질을 파괴시킬 뿐 아니라, 콜라겐의 결핍을 초래함으로써 결합조직을 손상시킨다. 뿐만 아니라, 활성산소는 세포들 사이의 공간에서 많은 양의 물을 함유하는 능력을 가지고 있어 피부의 탄력성을 유지하며 충격을 흡수하는 역할을 하는 히알루론산 사슬도 절단하여, 피부 탄력 및 피부 수분을 감소시키고, 이에 따라 피부 노화를 가속화시키게 한다.Third, active oxygen that causes damage to skin cells can be mentioned. When excessively active oxygen is present, it breaks down the body's antioxidant defense system and damages cellular components such as proteins, lipids, and DNA. As a result, cell functions are altered and ultimately skin aging can be accelerated. In addition, active oxygen not only directly destroys collagen by acting on collagen metabolism, but also damages connective tissue by causing collagen deficiency. In addition, active oxygen has the ability to contain a large amount of water in the space between cells, maintaining skin elasticity and cutting the hyaluronic acid chain, which plays a role in absorbing shock, reducing skin elasticity and skin moisture. and thereby accelerate skin aging.
이러한 활성산소는 흡연, 스트레스, 과도한 운동, 피부병, 바이러스 감염 및 자외선 등 우리의 건강을 위협하는 여러가지 인자들 뿐만 아니라, 생명을 유지하는 데 필수적인 호흡과 소화의 과정 중에서도 발생한다. These active oxygen are generated not only from various factors that threaten our health, such as smoking, stress, excessive exercise, skin disease, viral infection, and ultraviolet rays, but also during the process of breathing and digestion, which are essential for maintaining life.
이에, 상기와 같은 노화 요소로부터 피부를 보호하고, 손상된 피부를 개선시켜 맑고 탄력있는 피부로 유지하기 위한, 새로운 화장료 조성물에 대한 개발이 요구된다.Therefore, it is required to develop a new cosmetic composition to protect the skin from the aging factors and improve damaged skin to maintain clear and elastic skin.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 피부에 우수한 항염증 및 항산화 효과를 부여하며, 피부 미백 및 피부 노화 방지 효과를 발휘할 수 있는 화장료 조성물을 제공하고자 한다.The present invention is to solve the above problems, to provide a cosmetic composition that imparts excellent anti-inflammatory and antioxidant effects to the skin, and can exhibit skin whitening and anti-aging effects.
본 발명의 상기 및 다른 목적과 이점은 바람직한 실시예를 설명한 하기의 설명으로부터 분명해질 것이다.The above and other objects and advantages of the present invention will become apparent from the following description of preferred embodiments.
상기 목적은, 정제수 및 1,2-헥산다이올을 포함하는 용매; 글리세린; 세테아릴올리베이트; 비극성 보습 오일; 솔비탄올리베이트; 글루타티온; 하이드롤라이즈드 호밀 피토플라센타 추출물, 표고버섯 균사체 추출물, 살비아 추출물, 보골지열매 추출물, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 추출물; 및 향료;를 포함하는, 피부 미백용 화장료 조성물에 의해 달성될 수 있다.The above object is a solvent containing purified water and 1,2-hexanediol; glycerin; cetearyl olivate; non-polar moisturizing oil; sorbitan olivate; glutathione; An extract comprising at least one selected from the group consisting of hydrolyzed rye phytoplacenta extract, shiitake mushroom mycelium extract, salvia extract, bogolji fruit extract, and combinations thereof; It can be achieved by a cosmetic composition for skin whitening comprising; and fragrance.
구체적으로, 상기 비극성 보습 오일은, 하이드로제네이티드 올레핀 폴리머, 스쿠알란, 하이드로제네이티드 폴리데센, 카프릴릭/카프릭트리글리세라이드, 디카프릴릴 에테르, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 할 수 있다.Specifically, the non-polar moisturizing oil is at least one selected from the group consisting of hydrogenated olefin polymer, squalane, hydrogenated polydecene, caprylic/capric triglyceride, dicaprylyl ether, and combinations thereof It may be characterized by including.
구체적으로, 상기 화장료 조성물은, 피부컨디셔닝제, 점증제, 산화방지제, 킬레이팅제, 색소, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상의 첨가제를 추가로 포함하는 것을 특징으로 할 수 있다.Specifically, the cosmetic composition may be characterized in that it further comprises one or more additives selected from the group consisting of skin conditioning agents, thickeners, antioxidants, chelating agents, pigments, and combinations thereof.
구체적으로, 상기 피부컨디셔닝제는, 부틸렌글라이콜, 나이아신아마이드, 티아민에이치씨엘, 피리독신, 바이오틴, 사이아노코발아민, 리보플라빈, 폴릭애씨드, 메나다이온, 바이오플라보노이드, 아스코빅애씨드, 판테놀, 트라넥사믹애씨드, 에틸헥실글리세린, 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 할 수 있다.Specifically, the skin conditioning agent, butylene glycol, niacinamide, thiamine HCL, pyridoxine, biotin, cyanocobalamin, riboflavin, polyacid, menadione, bioflavonoids, ascorbic acid, panthenol, tranec It may be characterized in that it includes at least one selected from the group consisting of samic acid, ethylhexylglycerin, and combinations thereof.
구체적으로, 상기 점증제는, 카보머, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머, 다이메티콘/비닐다이메티콘크로스폴리머, 다이메티콘크로스폴리머, 비닐다이메티콘, 하이드록시 메틸셀룰로오스, 하이드록시 에틸셀룰로오스, 하이드록시 프로필메틸셀룰로오스, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 할 수 있다.Specifically, the thickener is carbomer, acrylate / C10-30 alkyl acrylate crosspolymer, dimethicone / vinyl dimethicone crosspolymer, dimethicone crosspolymer, vinyl dimethicone, hydroxy methylcellulose, It may be characterized in that it includes at least one selected from the group consisting of hydroxy ethyl cellulose, hydroxy propyl methyl cellulose, and combinations thereof.
구체적으로, 상기 산화방지제는, 토코페릴아세테이트, 하이드록시아세토페논, 소듐아스코빌포스페이트, 펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 할 수 있다.Specifically, the antioxidant is one selected from the group consisting of tocopheryl acetate, hydroxyacetophenone, sodium ascorbyl phosphate, pentaerythrityltetra-di-t-butylhydroxyhydrocinnamate, and combinations thereof It may be characterized by including the above.
구체적으로, 상기 킬레이팅제는, 다이소듐이디티에이, 소듐다이포스페이트, 소듐트리포스페이트, 나이트릴로트리메틸렌포스포산, 에틸렌디아민테트라아세테이트, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 할 수 있다.Specifically, the chelating agent includes at least one selected from the group consisting of disodium EDTA, sodium diphosphate, sodium triphosphate, nitrilotrimethylenephosphonic acid, ethylenediaminetetraacetate, and combinations thereof It can be characterized by doing.
구체적으로, 상기 화장료 조성물은, 유연화장수, 크림, 앰플, 젤, 클렌징폼, 팩, 스프레이, 파우더, 및 이들의 조합들로 이루어진 군으로부터 선택된 하나 이상으로 제형화된 것을 특징으로 할 수 있다.Specifically, the cosmetic composition may be formulated with one or more selected from the group consisting of softening lotion, cream, ampoule, gel, cleansing foam, pack, spray, powder, and combinations thereof.
본 발명에 따르면, 피부 적용 시 세포 독성 뿐만 아니라 자극, 발적 등의 안전성 문제가 발생하지 않으면서도 항산화 활성과 항염증 활성이 우수하며, 자외선 등 외부 자극으로부터 손상된 피부를 보호함으로써 피부 미백 효과를 나타낼 수 있다.According to the present invention, when applied to the skin, it has excellent antioxidant activity and anti-inflammatory activity without causing safety problems such as irritation and redness as well as cytotoxicity, and can exhibit a skin whitening effect by protecting damaged skin from external stimuli such as ultraviolet rays. there is.
또한, 본 발명에 따른 피부 미백용 화장료 조성물은 끈적이지 않고 촉촉한 마무리감을 나타내어 사용성이 우수하며, 장기 보관 시에도 층 분리 등 변형되지 않고 우수한 제형 안정성을 나타낼 수 있다.In addition, the cosmetic composition for skin whitening according to the present invention exhibits a non-sticky and moist finish and thus has excellent usability, and can exhibit excellent formulation stability without deformation such as layer separation even during long-term storage.
다만, 본 발명의 효과들은 이상에서 언급한 효과로 제한되지 않으며, 언급되지 않은 또 다른 효과들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the effects of the present invention are not limited to the effects mentioned above, and other effects not mentioned will be clearly understood by those skilled in the art from the description below.
도 1은, 본 발명의 일 실시예에 따른 피부 미백용 화장료 조성물의 피부 미백 효과 실험에서, Mexameter®를 이용해 측정한 시간에 따른 M-값(멜라닌 지수)의 개선율 변화를 나타낸 그래프이다.Figure 1 is a graph showing the change in the improvement rate of M-value (melanin index) over time measured using Mexameter ® in a skin whitening effect test of a cosmetic composition for skin whitening according to an embodiment of the present invention.
이하, 본 발명의 실시예와 도면을 참조하여 본 발명을 상세히 설명한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위해 예시적으로 제시한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가지는 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in detail with reference to embodiments and drawings of the present invention. These examples are only presented as examples to explain the present invention in more detail, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples. .
또한, 달리 정의하지 않는 한, 본 명세서에서 사용되는 모든 기술적 및 과학적 용어는 본 발명이 속하는 기술 분야의 숙련자에 의해 통상적으로 이해되는 바와 동일한 의미를 가지며, 상충되는 경우에는, 정의를 포함하는 본 명세서의 기재가 우선할 것이다.In addition, unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of skill in the art to which this invention belongs, and in case of conflict, this specification including definitions of will take precedence.
도면에서 제안된 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다. 그리고, 어떤 부분이 어떤 구성 요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. 또한, 명세서에서 기술한 "부"란, 특정 기능을 수행하는 하나의 단위 또는 블록을 의미한다.In order to clearly explain the proposed invention in the drawings, parts irrelevant to the description are omitted, and similar reference numerals are attached to similar parts throughout the specification. And, when a certain component is said to "include", this means that it may further include other components without excluding other components unless otherwise stated. Also, a “unit” described in the specification means one unit or block that performs a specific function.
각 단계들에 있어 식별부호(제1, 제2, 등)는 설명의 편의를 위하여 사용되는 것으로 식별부호는 각 단계들의 순서를 설명하는 것이 아니며, 각 단계들은 문맥상 명백하게 특정 순서를 기재하지 않는 이상 명기된 순서와 다르게 실시될 수 있다. 즉, 각 단계들은 명기된 순서와 동일하게 실시될 수도 있고 실질적으로 동시에 실시될 수도 있으며 반대의 순서대로 실시될 수도 있다.In each step, the identification code (first, second, etc.) is used for convenience of description, and the identification code does not describe the order of each step, and each step does not clearly describe a specific order in context. It may be performed differently from the order specified above. That is, each step may be performed in the same order as specified, may be performed substantially simultaneously, or may be performed in the reverse order.
본 발명에서 사용되는 용어, "추출물"은 원물의 추출 처리에 의하여 얻어지는 추출액, 상기 추출액의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조정제물이나 정제물, 또는 이들의 혼합물 등, 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함할 수 있다. 본 발명의 상기 추출물은, 상기 각각의 해당 식물의 천연, 잡종 또는 변종 식물로부터 추출될 수 있고, 식물 조직 배양물로부터도 추출이 가능하다. As used herein, the term "extract" refers to an extract obtained by extraction of raw material, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, a crude or purified product of the extract, or a mixture thereof, The extract itself and extracts of all formulations that can be formed using the extract may be included. The extract of the present invention may be extracted from natural, hybrid or mutant plants of each corresponding plant, and may also be extracted from plant tissue culture.
본 발명의 상기 원물의 추출에 있어서, 상기 추출물을 추출하는 방법은 특별히 제한되지 아니하며, 당해 기술분야에서 통상적으로 사용하는 방법에 따라 추출할 수 있다. 상기 추출 방법의 비제한적인 예로는, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등을 들 수 있으며, 이들은 단독으로 수행되거나 2 종 이상의 방법을 병용하여 수행될 수 있다.In the extraction of the raw material of the present invention, a method for extracting the extract is not particularly limited, and may be extracted according to a method commonly used in the art. Non-limiting examples of the extraction method include a hot water extraction method, an ultrasonic extraction method, a filtration method, a reflux extraction method, and the like, which may be performed alone or in combination of two or more methods.
본 발명에서 상기 원물을 추출하는데 사용되는 추출 용매의 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 추출 용매의 비제한적인 예로는 물; 메탄올, 에탄올, 프로필알코올, 부틸알코올 등의 C1 내지 C4의 저급 알코올; 글리세린, 부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올; 및 에틸아세테이트 등의 탄화수소계 용매; 또는 이들의 혼합물을 사용할 수 있으며, 바람직하게, 정제수, 저급알코올, 1,3-부틸렌글리콜, 에틸아세테이트를 단독으로 사용하거나 2종 이상 혼합하여 사용할 수 있다. In the present invention, the type of extraction solvent used to extract the raw material is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the extraction solvent include water; C1 to C4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; polyhydric alcohols such as glycerin, butylene glycol, and propylene glycol; and hydrocarbon solvents such as ethyl acetate; Or a mixture thereof may be used, and preferably, purified water, lower alcohol, 1,3-butylene glycol, and ethyl acetate may be used alone or in combination of two or more.
본 발명에서 열수 추출 또는 냉침 추출한 추출물은, 부유하는 고체 입자를 제거하기 위해 여과, 예를 들어 나일론 등을 이용해 입자를 걸러내거나 냉동여과법 등을 이용해 여과한 후, 그대로 사용하거나 이를 동결건조, 열풍건조, 분무건조 등을 이용해 건조시켜 사용할 수 있다.In the present invention, the extract obtained by hot water extraction or cold brewing is filtered to remove floating solid particles, for example, by filtering out particles using nylon or the like, or by using cryofiltration, and then used as is or freeze-dried or hot-air-dried. , spray drying, etc. can be used after drying.
이하, 첨부된 도면을 참조하여 본원의 구현예 및 실시예를 상세히 설명한다. 그러나, 본원의 이러한 구현예 및 실시예와 도면에 제한되지 않을 수 있다.Hereinafter, embodiments and embodiments of the present disclosure will be described in detail with reference to the accompanying drawings. However, it may not be limited to these implementations and examples and drawings herein.
본원의 일 측면은, 정제수 및 1,2-헥산다이올을 포함하는 용매; 글리세린; 세테아릴올리베이트; 비극성 보습 오일; 솔비탄올리베이트; 글루타티온; 하이드롤라이즈드 호밀 피토플라센타 추출물, 표고버섯 균사체 추출물, 살비아 추출물, 보골지열매 추출물, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 추출물; 및 향료;를 포함하는, 피부 미백용 화장료 조성물을 제공한다.One aspect of the present application, a solvent containing purified water and 1,2-hexanediol; glycerin; cetearyl olivate; non-polar moisturizing oil; sorbitan olivate; glutathione; An extract comprising at least one selected from the group consisting of hydrolyzed rye phytoplacenta extract, shiitake mushroom mycelium extract, salvia extract, bogolji fruit extract, and combinations thereof; It provides a cosmetic composition for skin whitening comprising; and fragrance.
본 발명에 따른 피부 미백용 화장료 조성물은, 피부 적용 시 세포 독성 뿐만 아니라 자극, 발적 등의 안전성 문제가 발생하지 않으면서도 항산화 활성과 항염증 활성이 우수하며, 자외선 등 외부 자극으로부터 손상된 피부를 보호함으로써 피부 미백 효과를 나타낼 수 있고, 끈적이지 않고 촉촉한 마무리감을 나타내어 사용성이 우수하며, 장기 보관 시에도 층 분리 등 변형되지 않고 우수한 제형 안정성을 나타낼 수 있다는 장점을 갖는다.The cosmetic composition for skin whitening according to the present invention has excellent antioxidant activity and anti-inflammatory activity without causing safety problems such as irritation and redness as well as cytotoxicity when applied to the skin, and protects damaged skin from external stimuli such as ultraviolet rays. It has the advantage that it can exhibit a skin whitening effect, exhibits a moist finish without being sticky, and has excellent usability, and can exhibit excellent formulation stability without deformation such as layer separation even during long-term storage.
일 실시예에 있어서, 상기 용매는 상기 화장료 조성물에 약 75 내지 85 중량%로 포함될 수 있다. 만약, 상기 용매가 약 75 중량% 미만으로 포함될 경우 구성성분이 충분히 용해되지 않을 수 있으며, 약 85 중량%를 초과할 경우 화장료 조성물의 피부 미백 효과가 충분히 발휘되지 않을 수 있다.In one embodiment, the solvent may be included in about 75 to 85% by weight of the cosmetic composition. If the solvent is included in less than about 75% by weight, the components may not be sufficiently dissolved, and if it exceeds about 85% by weight, the skin whitening effect of the cosmetic composition may not be sufficiently exhibited.
일 실시예에 있어서, 상기 글리세린은 화장료 조성물의 피부 보습 및 피부 개선 효과를 위해 포함되는 것으로, 상기 화장료 조성물에 약 0.1 내지 10 중량%로 포함되는 것일 수 있다. 만약, 상기 글리세린이 약 0.1 중량% 미만으로 포함될 경우 상기 글리세린을 포함함에 따라 나타나는 효과가 충분히 발휘되지 않을 수 있으며, 약 10 중량%를 초과할 경우 사용감이 하락할 수 있다.In one embodiment, the glycerin is included for the skin moisturizing and skin improving effect of the cosmetic composition, and may be included in about 0.1 to 10% by weight in the cosmetic composition. If the glycerin is included in an amount of less than about 0.1% by weight, the effect resulting from the inclusion of the glycerin may not be sufficiently exhibited, and if it exceeds about 10% by weight, the feeling of use may be reduced.
일 실시예에 있어서, 상기 세테아릴올리베이트는 상기 화장료 조성물에 포함되는 구성성분들을 용이하게 혼합시키기 위해 첨가되는 것으로, 상기 화장료 조성물에 약 0.1 내지 10 중량%로 포함되는 것일 수 있다. 만약, 약 0.1 중량% 미만으로 포함될 경우 화장료 조성물의 구성성분이 서로 용이하게 혼합되지 않아 뭉침 또는 가라앉는 현상이 발생할 수 있고, 약 10 중량%를 초과할 경우 지나치게 많은 거품이 발생할 수 있다. 바람직하게, 상기 세테아릴올리베이트는 약 0.1 내지 5 중량%로 포함될 수 있다.In one embodiment, the cetearyl olivate is added to easily mix the components included in the cosmetic composition, and may be included in the cosmetic composition at about 0.1 to 10% by weight. If it is included in less than about 0.1% by weight, the components of the cosmetic composition may not be easily mixed with each other, resulting in aggregation or sinking, and if it exceeds about 10% by weight, too much foam may be generated. Preferably, the cetearyl olivate may be included in about 0.1 to 5% by weight.
일 실시예에 있어서, 상기 비극성 보습 오일은, 탄화수소로만 이루어진 하이드로 카본 오일류를 말하며 이중 1 종 이상을 선택하여 사용한다. 예를 들어, 하이드로제네이티드 올레핀 폴리머, 스쿠알란, 하이드로제네이티드 폴리데센, 카프릴릭/카프릭트리글리세라이드, 디카프릴릴 에테르, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함할 수 있다. 상기 비극성 보습 오일은 우수한 보습 효과와 함께 피부 탄력 개선 및 피부 진정 효과를 나타낼 수 있다. 구체적으로, 상기 비극성 보습 오일은 카프릴릭/카프릭트리글리세라이드를 포함하는 것일 수 있다.In one embodiment, the non-polar moisturizing oil refers to hydrocarbon oils composed only of hydrocarbons, and at least one of them is selected and used. For example, it may include one or more selected from the group consisting of hydrogenated olefin polymer, squalane, hydrogenated polydecene, caprylic/capric triglyceride, dicaprylyl ether, and combinations thereof. . The non-polar moisturizing oil may exhibit skin elasticity improvement and skin soothing effects along with an excellent moisturizing effect. Specifically, the non-polar moisturizing oil may include caprylic/capric triglyceride.
일 실시예에 있어서, 상기 카프릴릭/카프릭트리글리세라이드는 상기 화장료 조성물에 약 0.1 내지 15 중량%로 포함되는 것일 수 있다. 만약, 상기 카프릴릭/카프릭트리글리세라이드가 0.1 중량% 미만으로 포함될 경우 상기 비극성 보습 오일을 포함함에 따라 나타나는 보습, 피부 탄력 개선 및 피부 진정 효과가 충분히 발휘되지 않을 수 있으며, 약 15 중량%를 초과할 경우 층 분리 현상이 발생할 수 있다. 바람직하게, 상기 카프릴릭/카프릭트리글리세라이드는 약 1 내지 10 중량%로 포함될 수 있다.In one embodiment, the caprylic / capric triglyceride may be contained in about 0.1 to 15% by weight of the cosmetic composition. If the caprylic / capric triglyceride is included in less than 0.1% by weight, the moisturizing, skin elasticity improvement and skin soothing effects caused by the inclusion of the non-polar moisturizing oil may not be sufficiently exhibited, and about 15% by weight If exceeded, layer separation may occur. Preferably, the caprylic/capric triglyceride may be included in an amount of about 1 to 10% by weight.
일 실시예에 있어서, 상기 솔비탄올리베이트는, 상기 화장료 조성물에 포함되는 구성성분들을 용이하게 혼합시키기 위해 첨가되는 것으로, 상기 화장료 조성물에 약 0.01 내지 5 중량%로 포함되는 것일 수 있다. 만약, 약 0.1 중량% 미만으로 포함될 경우 화장료 조성물의 구성성분이 서로 용이하게 혼합되지 않아 뭉침 또는 가라앉는 현상이 발생할 수 있고, 약 10 중량%를 초과할 경우 지나치게 많은 거품이 발생할 수 있다. 바람직하게, 상기 솔비탄올리베이트는 약 0.1 내지 5 중량%로 포함될 수 있다.In one embodiment, the sorbitan olivate is added to easily mix the components included in the cosmetic composition, and may be included in the cosmetic composition at about 0.01 to 5% by weight. If it is included in less than about 0.1% by weight, the components of the cosmetic composition may not be easily mixed with each other, resulting in aggregation or sinking, and if it exceeds about 10% by weight, too much foam may be generated. Preferably, the sorbitan olivate may be included in about 0.1 to 5% by weight.
일 실시예에 있어서, 상기 글루타티온은, 글루탐산, 시스테인, 글리신의 세 가지 아미노산으로 이루어진 결정성 펩타이드이자 강력한 항산화제로서, 상기 화장료 조성물에 포함되어 높은 피부 미백 효과를 나타낼 수 있다.In one embodiment, the glutathione, as a crystalline peptide consisting of three amino acids, glutamic acid, cysteine, and glycine, and a strong antioxidant, can exhibit a high skin whitening effect when included in the cosmetic composition.
일 실시예에 있어서, 상기 글루타티온은 약 0.000001 내지 0.001 중량%로 포함되는 것일 수 있다. 만약, 상기 글루타티온이 약 0.000001 중량% 미만으로 포함될 경우 상기 글루타티온을 포함함에 따라 나타나는 피부 미백 효과가 충분히 발휘되지 않을 수 있고, 약 0.001 중량%를 초과할 경우 피부 자극이 나타날 수 있다.In one embodiment, the glutathione may be included in about 0.000001 to 0.001% by weight. If the glutathione is included in an amount of less than about 0.000001% by weight, the skin whitening effect resulting from the inclusion of the glutathione may not be sufficiently exhibited, and if the content exceeds about 0.001% by weight, skin irritation may occur.
일 실시예에 있어서, 상기 추출물은, 하이드롤라이즈드 호밀 피토플라센타 추출물, 표고버섯 균사체 추출물, 살비아 추출물, 보골지열매 추출물, 및 이들의 조합들로 이루어진 군으로부터 선택된 하나 이상을 포함할 수 있으며, 구체적으로는 상기 하이드롤라이즈드 호밀 피토플라센타 추출물, 표고버섯 균사체 추출물, 살비아 추출물, 및 보골지열매 추출물을 모두 포함하는 것일 수 있다.In one embodiment, the extract may include one or more selected from the group consisting of hydrolyzed rye phytoplacenta extract, shiitake mushroom mycelium extract, salvia extract, bogolji fruit extract, and combinations thereof Specifically, it may include all of the hydrolyzed rye phytoplacenta extract, shiitake mushroom mycelium extract, salvia extract, and bogolji fruit extract.
일 실시예에 있어서, 상기 하이드롤라이즈드 호밀 피토플라센타 추출물은, 호밀 Secale cereale의 씨플라센타를 추출하여, 산, 효소 혹은 다른 방법으로 가수분해한 것을 의미할 수 있다. 상기 하이드롤라이즈드 호밀 피토플라센타 추출물은 우수한 피부 보습 효과를 나타내어 피부를 자극으로부터 보호할 수 있으며, 이에 따라 피부 진정 효과를 나타낼 수 있다.In one embodiment, the hydrolyzed rye phytoplacenta extract may mean that rye Secale cereale's cipoplacenta is extracted and hydrolyzed with an acid, enzyme, or other method. The hydrolyzed rye phytoplacenta extract exhibits an excellent skin moisturizing effect and can protect the skin from irritation, thereby exhibiting a skin soothing effect.
일 실시예에 있어서, 상기 하이드롤라이즈드 호밀 피토플라센타 추출물은 약 0.000001 내지 0.001 중량%로 포함될 수 있다. 만약, 상기 하이드롤라이즈드 호밀 피토플라센타 추출물이 0.000001 중량% 미만으로 포함될 경우 상기 서술한 효과를 충분히 발휘하지 못할 수 있고, 약 0.001 중량%를 초과할 경우 다른 성분과의 혼합성이 저해될 수 있다.In one embodiment, the hydrolyzed rye phytoplacenta extract may be included in about 0.000001 to 0.001% by weight. If the hydrolyzed rye phytoplacenta extract is included in an amount of less than 0.000001% by weight, the above-described effect may not be sufficiently exhibited, and if it exceeds about 0.001% by weight, mixability with other components may be impaired. .
일 실시예에 있어서, 상기 표고버섯 균사체 추출물은, 표고버섯의 균사체를 액체배양하여 추출한 것을 의미할 수 있다. 상기 표고버섯 균사체 추출물은 우수한 항산화 및 항균성을 나타내어 피부 보습, 피부 진정 효과를 나타냄과 동시에 화장료 조성물에 첨가 시 우수한 제형 안정성을 나타낼 수 있다.In one embodiment, the shiitake mushroom mycelium extract may mean that the mycelium of shiitake mushroom was extracted by liquid culture. The shiitake mushroom mycelium extract exhibits excellent antioxidant and antibacterial properties, thereby exhibiting skin moisturizing and skin soothing effects, and may exhibit excellent formulation stability when added to a cosmetic composition.
일 실시예에 있어서, 상기 표고버섯 균사체 추출물은 약 0.00001 내지 0.001 중량%로 포함될 수 있다. 만약, 상기 표고버섯 균사체 추출물이 0.00001 중량% 미만으로 포함될 경우 상기 서술한 효과를 충분히 발휘하지 못할 수 있고, 약 0.001 중량%를 초과할 경우 다른 성분과의 혼합성이 저해될 수 있다.In one embodiment, the shiitake mushroom mycelium extract may be included in about 0.00001 to 0.001% by weight. If the shiitake mushroom mycelium extract is included in less than 0.00001% by weight, the above-described effect may not be sufficiently exhibited, and if it exceeds about 0.001% by weight, mixability with other components may be impaired.
일 실시예에 있어서, 상기 살비아 추출물은, 세이지잎추출물이라고도 불리우며, 세이지의 잎을 열수 추출하여 수득된 것을 의미한다. 상기 살비아 추출물은 항염 및 항균 효과를 나타내어 문제성 피부를 진정시키는 데 도움이 될 뿐만 아니라, 소독 및 살균 작용을 나타내어 화장료 조성물에 첨가 시 우수한 제형 안정성을 나타낼 수 있다.In one embodiment, the salvia extract, also called sage leaf extract, means obtained by hot water extraction of sage leaves. The salvia extract exhibits anti-inflammatory and antibacterial effects to help soothe problematic skin, and exhibits disinfection and sterilization effects, thereby exhibiting excellent formulation stability when added to a cosmetic composition.
일 실시예에 있어서, 상기 살비아 추출물은 약 0.00001 내지 0.001 중량%로 포함될 수 있다. 만약, 상기 살비아 추출물이 0.00001 중량% 미만으로 포함될 경우 상기 서술한 효과를 충분히 발휘하지 못할 수 있고, 약 0.001 중량%를 초과할 경우 다른 성분과의 혼합성이 저해될 수 있다.In one embodiment, the salvia extract may be included in about 0.00001 to 0.001% by weight. If the salvia extract is included in an amount of less than 0.00001% by weight, the above-described effect may not be sufficiently exhibited, and if it exceeds about 0.001% by weight, mixing with other components may be impaired.
일 실시예에 있어서, 상기 보골지열매 추출물은, 보골지 Psoralea corylifolia의 열매에서 추출한 것을 의미할 수 있다. 상기 보골지열매 추출물은 바쿠치올을 다량으로 함유하여 항균 작용을 나타내며, 우수한 항노화 효과를 나타내어 피부 미백 효능을 발휘할 수 있다.In one embodiment, the bogolji fruit extract may refer to an extract from the fruit of bogolji Psoralea corylifolia. The bogol berry extract contains a large amount of bakuchiol to exhibit antibacterial activity, and exhibits excellent anti-aging effect to exhibit skin whitening efficacy.
일 실시예에 있어서, 상기 보골지열매 추출물은 약 0.00001 내지 0.001 중량%로 포함될 수 있다. 만약, 상기 보골지열매 추출물이 0.00001 중량% 미만으로 포함될 경우 상기 서술한 효과를 충분히 발휘하지 못할 수 있고, 약 0.001 중량%를 초과할 경우 다른 성분과의 혼합성이 저해될 수 있다.In one embodiment, the bogolji fruit extract may be included in about 0.00001 to 0.001% by weight. If the bogolji fruit extract is included in less than 0.00001% by weight, the above-described effect may not be sufficiently exhibited, and if it exceeds about 0.001% by weight, mixing with other components may be impaired.
일 실시예에 있어서, 상기 향료는, 불쾌한 향취를 줄여주어 소비자 만족도를 향상시키기 위한 것으로, 약 0.01 내지 3 중량%로 포함되는 것일 수 있다. 만약, 약 0.01 중량% 미만으로 포함될 경우 향취가 개선되지 않을 수 있고, 약 3 중량%를 초과할 경우 피부 자극을 나타낼 수 있다.In one embodiment, the spice is intended to improve consumer satisfaction by reducing an unpleasant odor, and may be included in an amount of about 0.01 to 3% by weight. If included in less than about 0.01% by weight, fragrance may not be improved, and if it exceeds about 3% by weight, skin irritation may occur.
일 실시예에 있어서, 상기 화장료 조성물은 용과 껍질 추출물을 추가 포함하는 것일 수 있다. 상기 용과는 선인장과에 속하는 귀화 재배 작물이며 원산지는 중앙아메리카 아열대지역이나 피타야로 불리며 국내 제주에서도 재배된다. 용과는 열매가 익을수록 알칼로이드 색소 성분이 증가하며 병해충에 강하여 무농약 재배가 가능하고 탄수화물, 섬유질, 단백질과 지방산이 풍부하여 건강식으로 이용되고 있다. 상기 용과 껍질 추출물은 용과 껍질의 약 10 배의 주정을 가한 뒤 약 25℃ 내지 45℃의 온도 범위에서 약 18 시간 내지 약 48 시간 동안 가열함으로써 추출액을 수득하고, 상기 수득된 추출액을 약 1,000 내지 약 6,000 rpm에서 원심분리하고 감압 농축하여 수득되는 것일 수 있다.In one embodiment, the cosmetic composition may further include a dragon fruit peel extract. The dragon fruit is a naturalized cultivated crop belonging to the cactus family, and its origin is called the Central American subtropical region or pitaya, and is also cultivated in Jeju, Korea. As the fruit ripens, the alkaloid pigment component increases, and because it is resistant to pests and pests, it can be cultivated without pesticides and is rich in carbohydrates, fiber, protein and fatty acids, so it is used as a healthy food. The dragon fruit peel extract is obtained by heating for about 18 hours to about 48 hours at a temperature range of about 25 ℃ to 45 ℃ after adding about 10 times the alcohol of dragon fruit skin, and the obtained extract is about 1,000 to about It may be obtained by centrifugation at 6,000 rpm and concentration under reduced pressure.
상기 용과 껍질에 포함된 점액질(mucilage)은 단백질의 흡수를 촉진시키고 피부에 적용 시 점막의 보호와 가려움 등의 자극을 완화시켜주는 것으로 알려져 있으며 천연 보습제로도 이용된다. 또한, 식물로부터 유래하여 알러지나 부작용이 적다. 이에 따라, 상기 용과 껍질 추출물을 포함하는 화장료 조성물은, 항산화 및 항염증 효능 뿐만 아니라, 피부 미백, 피부 진정 및 피부 재생 효과를 나타낼 수 있다.The mucilage contained in the peel of the dragon fruit promotes protein absorption and is known to protect the mucous membrane and relieve irritation such as itching when applied to the skin, and is also used as a natural moisturizer. In addition, it is derived from plants, so there are few allergies or side effects. Accordingly, the cosmetic composition containing the dragon fruit peel extract may exhibit antioxidant and anti-inflammatory effects, as well as skin whitening, skin soothing and skin regeneration effects.
일 실시예에 있어서, 상기 용과 껍질 추출물은 약 0.01 내지 1 중량%로 포함되는 것일 수 있다. 만약, 상기 용과 껍질 추출물이 약 0.01 중량% 미만으로 포함될 경우 용과 껍질 추출물을 포함함에 따라 나타나는 피부 미백, 피부 진정 및 피부 재생 효과가 충분히 발휘되지 않을 수 있으며, 약 1 중량%를 초과할 경우 피부 자극을 나타낼 수 있다.In one embodiment, the dragon fruit peel extract may be included in about 0.01 to 1% by weight. If the dragon fruit peel extract is included in an amount of less than about 0.01% by weight, skin whitening, skin soothing and skin regeneration effects may not be sufficiently exhibited due to the inclusion of the dragon fruit skin extract, and if it exceeds about 1 weight %, skin irritation may occur. can represent
일 실시예에 있어서, 상기 화장료 조성물은 복령추출물을 추가 포함하는 것일 수 있다. 상기 복령추출물은 담자균류 민주름버섯목에 속하는 버섯인 복령(Tuckahoe)의 균사체 또는 균핵에서 추출된 것을 의미한다. 상기 복령은 트리터페노이드 계열인 유브리코익산(eubricoic acid), 파키믹산(pachymic acid), 투물로스산(tumulosic acid) 및 피노콜산(pinocolic acid) 등이 함유하고 있으며, 그에 따라 피부 건조에 의한 민감 반응을 진정시키고, 피부의 안색을 정화하여 피부 미백 효과를 나타낼 수 있다. 또한, 상기 복령추출물은 피부 자극을 나타내지 않으므로, 상기 복령추출물을 포함하는 화장료 조성물은 여드름 등 문제성 피부를 진정시키고 피부 보습을 부여하여 피부를 개선하는 효과를 나타낼 수 있다.In one embodiment, the cosmetic composition may further include a bokryeong extract. The Bokryeong extract refers to an extract from the mycelium or sclerotium of Tuckahoe, a mushroom belonging to the basidiomycete Mushroom Order. The bokryeong contains triterpenoids such as eubricoic acid, pachymic acid, tumulosic acid and pinocolic acid, and thus sensitive skin due to dryness. It can soothe the reaction, purify the complexion of the skin, and show a skin whitening effect. In addition, since the Bokryeong extract does not show skin irritation, the cosmetic composition containing the Bokryeong extract can show the effect of improving skin by soothing problem skin such as acne and moisturizing the skin.
일 실시예에 있어서, 상기 복령추출물은 약 0.01 내지 1 중량%로 포함되는 것일 수 있다. 만약, 상기 복령추출물이 약 0.01 중량% 미만으로 포함될 경우 복령추출물을 포함함에 따라 나타나는 피부 진정 및 피부 미백 효과가 충분히 발휘되지 않을 수 있으며, 약 1 중량%를 초과할 경우 피부 자극을 나타낼 수 있다.In one embodiment, the bokryeong extract may be contained in about 0.01 to 1% by weight. If, when the Bokryeong extract is included in less than about 0.01% by weight, the skin soothing and skin whitening effect that appears according to the inclusion of the Bokryeong extract may not be sufficiently exerted, and if it exceeds about 1% by weight, it may cause skin irritation.
일 실시예에 있어서, 상기 화장료 조성물은 씨벅톤 오일을 추가 포함하는 것일 수 있다. 상기 씨벅톤 오일은 비타민, 플라보노이드, 필수 아미노산, 및 지방산을 포함함으로써, 높은 항산화 및 항염증 효과를 나타낼 수 있다. 구체적으로, 상기 씨벅톤 오일은 풍부한 티아민, 리보플라빈, 피리독신 등의 비타민 B, 비타민 A, 비타민 K, 및 비타민 E를 포함함에 따라 피부에 활기를 부여하고 탄력을 주며, 주름 및 노화를 방지할 수 있으며, 우수한 산화방지 효능를 나타내어 화장료 조성물에 추가 포함 시 저장 및 제형 안정성 효과를 부여할 수 있다.In one embodiment, the cosmetic composition may further include sea buckthorn oil. The sea buckthorn oil may exhibit high antioxidant and anti-inflammatory effects by including vitamins, flavonoids, essential amino acids, and fatty acids. Specifically, the sea buckthorn oil contains abundant vitamins such as thiamine, riboflavin, and pyridoxine, vitamin A, vitamin K, and vitamin E, thereby providing vitality and elasticity to the skin, preventing wrinkles and aging, , It exhibits excellent antioxidant efficacy and can impart storage and formulation stability effects when additionally included in a cosmetic composition.
일 실시예에 있어서, 상기 씨벅톤 오일은 약 0.01 내지 1 중량%로 포함되는 것일 수 있다. 만약, 상기 씨벅톤 오일이 약 0.01 중량% 미만으로 포함될 경우 씨벅톤 오일을 포함함에 따라 나타나는 저장 및 제형 안정성 효과가 충분히 발휘되지 않을 수 있으며, 약 1 중량%를 초과할 경우 피부 자극을 나타낼 수 있다.In one embodiment, the seabuckthorn oil may be contained in about 0.01 to 1% by weight. If the seabuckthorn oil is included in less than about 0.01% by weight, the storage and formulation stability effects resulting from the inclusion of seabuckthorn oil may not be sufficiently exhibited, and if it exceeds about 1% by weight, skin irritation may occur. .
일 실시예에 있어서, 상기 화장료 조성물은, 피부컨디셔닝제, 점증제, 산화방지제, 킬레이팅제, 색소, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상의 첨가제를 추가로 포함할 수 있다.In one embodiment, the cosmetic composition may further include one or more additives selected from the group consisting of skin conditioning agents, thickeners, antioxidants, chelating agents, pigments, and combinations thereof.
일 실시예에 있어서, 상기 피부컨디셔닝제는, 부틸렌글라이콜, 나이아신아마이드, 티아민에이치씨엘, 피리독신, 바이오틴, 사이아노코발아민, 리보플라빈, 폴릭애씨드, 메나다이온, 바이오플라보노이드, 아스코빅애씨드, 판테놀, 트라넥사믹애씨드, 에틸헥실글리세린, 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함함으로써 피부 진정, 피부 미백, 피부 보습 효과를 나타낼 수 있다. 구체적으로, 상기 피부컨디셔닝제는 부틸렌글라이콜, 나이아신아마이드, 티아민에이치씨엘, 피리독신, 바이오틴, 사이아노코발아민, 리보플라빈, 폴릭애씨드, 메나다이온, 바이오플라보노이드, 아스코빅애씨드, 판테놀, 트라넥사믹애씨드, 및 에틸헥실글리세린을 모두 포함하는 것일 수 있다.In one embodiment, the skin conditioning agent is butylene glycol, niacinamide, thiamine HCL, pyridoxine, biotin, cyanocobalamin, riboflavin, polyacid, menadione, bioflavonoids, ascorbic acid, panthenol , tranexamic acid, ethylhexylglycerin, and at least one selected from the group consisting of combinations thereof may exhibit skin soothing, skin whitening, and skin moisturizing effects. Specifically, the skin conditioning agent is butylene glycol, niacinamide, thiamine HCL, pyridoxine, biotin, cyanocobalamin, riboflavin, polyacid, menadione, bioflavonoids, ascorbic acid, panthenol, tranexamic It may contain both acid and ethylhexylglycerin.
일 실시예에 있어서, 상기 피부컨디셔닝제에 포함되는 성분들은 각각 약 0.000001 내지 10 중량%으로 포함될 수 있다. 만약, 약 0.000001 중량% 미만으로 포함될 경우 상기 성분을 포함함에 따라 나타나는 효과를 충분히 발휘하지 못할 수 있으며, 약 10 중량%을 초과할 경우 피부 자극을 나타낼 수 있다. 예를 들어, 약 0.000001 내지 10 중량%, 약 0.000001 내지 0.00001 중량%, 약 0.0001 내지 0.01 중량%, 약 0.01 내지 1 중량%, 또는 약 1 내지 10 중량%일 수 있다.In one embodiment, the components included in the skin conditioning agent may be included in about 0.000001 to 10% by weight, respectively. If it is included in less than about 0.000001% by weight, it may not be able to sufficiently exhibit the effect of including the above component, and if it exceeds about 10% by weight, it may cause skin irritation. For example, about 0.000001 to 10 weight percent, about 0.000001 to 0.00001 weight percent, about 0.0001 to 0.01 weight percent, about 0.01 to 1 weight percent, or about 1 to 10 weight percent.
일 실시예에 있어서, 상기 점증제는 화장료 조성물의 점도를 조절하기 위해 포함되는 것으로, 예를 들어, 카보머, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머, 다이메티콘/비닐다이메티콘크로스폴리머, 다이메티콘크로스폴리머, 비닐다이메티콘, 하이드록시 메틸셀룰로오스, 하이드록시 에틸셀룰로오스, 하이드록시 프로필메틸셀룰로오스, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함할 수 있다. 구체적으로, 상기 점증제는 카보머를 포함하는 것일 수 있다.In one embodiment, the thickener is included to adjust the viscosity of the cosmetic composition, for example, carbomer, acrylate / C10-30 alkyl acrylate crosspolymer, dimethicone / vinyl dimethicone cross It may include at least one selected from the group consisting of a polymer, dimethicone crosspolymer, vinyl dimethicone, hydroxy methyl cellulose, hydroxy ethyl cellulose, hydroxy propyl methyl cellulose, and combinations thereof. Specifically, the thickener may include a carbomer.
일 실시예에 있어서, 상기 카보머는 약 0.01 내지 3 중량%으로 포함되는 것일 수 있다. 만약, 약 0.01 중량% 미만으로 포함될 경우 제조되는 화장료 조성물이 지나치게 묽어 사용감이 하락할 수 있으며, 약 3 중량%를 초과할 경우 침전물이 발생할 수 있다.In one embodiment, the carbomer may be included in about 0.01 to 3% by weight. If it is included in less than about 0.01% by weight, the cosmetic composition prepared may be too thin and the feeling of use may decrease, and if it exceeds about 3% by weight, sediment may occur.
일 실시예에 있어서, 상기 산화방지제는 제조되는 화장료 조성물의 산화를 방지하여 보관 안정성을 향상시키기 위한 것으로, 예를 들어, 토코페릴아세테이트, 하이드록시아세토페논, 소듐아스코빌포스페이트, 펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함할 수 있다. 구체적으로, 상기 산화방지제는 토코페릴아세테이트를 포함하는 것일 수 있다.In one embodiment, the antioxidant is to improve storage stability by preventing oxidation of the cosmetic composition to be prepared, for example, tocopheryl acetate, hydroxyacetophenone, sodium ascorbyl phosphate, pentaerythrityl tetra- di-t-butylhydroxyhydrocinnamate, and at least one selected from the group consisting of combinations thereof. Specifically, the antioxidant may include tocopheryl acetate.
일 실시예에 있어서, 상기 토코페릴아세테이트는 약 0.000001 내지 0.001 중량%으로 포함되는 것일 수 있다. 만약, 약 0.000001 중량% 미만으로 포함될 경우 제조되는 화장료 조성물의 보관 안정성이 하락할 수 있으며, 약 0.001 중량%을 초과할 경우 다른 성분과의 혼합성이 저해될 수 있다.In one embodiment, the tocopheryl acetate may be contained in about 0.000001 to 0.001% by weight. If it is included in less than about 0.000001% by weight, the storage stability of the cosmetic composition prepared may decrease, and if it exceeds about 0.001% by weight, mixing with other components may be inhibited.
일 실시예에 있어서, 상기 킬레이팅제는, 다이소듐이디티에이, 소듐다이포스페이트, 소듐트리포스페이트, 나이트릴로트리메틸렌포스포산, 에틸렌디아민테트라아세테이트, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함할 수 있다. 구체적으로, 상기 킬레이팅제는 다이소듐이디티에이를 포함하는 것일 수 있다.In one embodiment, the chelating agent is one selected from the group consisting of disodium EDTA, sodium diphosphate, sodium triphosphate, nitrilotrimethylenephosphonic acid, ethylenediaminetetraacetate, and combinations thereof may contain more than Specifically, the chelating agent may include disodium EDTA.
일 실시예에 있어서, 상기 킬레이팅제는 상기 화장료 조성물의 약 0.01 내지 3 중량%로 포함되는 것일 수 있다. 만약, 약 0.01 중량% 미만일 경우 제조되는 화장료 조성물의 안정성이 하락할 수 있고, 약 3 중량%가 초과할 경우 피부 자극이 발생할 수 있다.In one embodiment, the chelating agent may be included in about 0.01 to 3% by weight of the cosmetic composition. If it is less than about 0.01% by weight, the stability of the cosmetic composition prepared may decrease, and if it exceeds about 3% by weight, skin irritation may occur.
일 실시예에 있어서, 상기 서술한 효과는 상기 서술한 구성성분을 모두 포함함에 따라 그 유기적인 상호작용에 의하여 발휘되는 것으로서, 상기 유효성분을 선택적으로 포함할 경우 상기 효과를 달성할 수 없을 수 있다.In one embodiment, the above-described effect is exerted by organic interaction as all of the above-described components are included, and the above effect may not be achieved when the active ingredient is selectively included. .
일 실시예에 있어서, 상기 화장료 조성물은, 서술한 성분들 외에 통상적으로 화장료 조성물을 제조하는 데 요구되는 성분들을 추가적으로 더욱 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, the cosmetic composition, in addition to the components described above, may additionally further include components typically required for preparing a cosmetic composition, but may not be limited thereto.
일 실시예에 있어서, 상기 화장료 조성물은, 유연화장수, 크림, 앰플, 젤, 클렌징폼, 팩, 스프레이, 파우더, 및 이들의 조합들로 이루어진 군으로부터 선택된 하나 이상으로 제형화된 것일 수 있다.In one embodiment, the cosmetic composition may be formulated with one or more selected from the group consisting of softening lotion, cream, ampoule, gel, cleansing foam, pack, spray, powder, and combinations thereof.
일 실시예에 있어서, 상기 화장료 조성물은 화장료의 제형 또는 사용 목적에 맞게 임의로 선정한 물질을 첨가할 수 있다. 예를 들어, 정제수, 유분, 계면활성제, 보습제, 고급 알코올, 증저점제, 킬레이트제, 색소, 지방산, 산화방지제, 방부제, 왁스, pH 조절제, 향료 등이 첨가될 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, the cosmetic composition may add a material arbitrarily selected according to the cosmetic formulation or purpose of use. For example, purified water, oil, surfactants, moisturizers, higher alcohols, thickeners, chelating agents, pigments, fatty acids, antioxidants, preservatives, waxes, pH adjusters, fragrances, etc. may be added, but may not be limited thereto. there is.
일 실시예에 있어서, 상기 화장료 조성물의 제형이 페이스트, 크림 또는 젤인 경우, 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등을 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, when the formulation of the cosmetic composition is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc as a carrier component Alternatively, zinc oxide may be included, but may not be limited thereto.
일 실시예에 있어서, 상기 화장료 조성물의 제형이 파우더 또는 스프레이인 경우, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더를 포함할 수 있고, 특히, 스프레이인 경우, 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, when the formulation of the cosmetic composition is a powder or spray, it may include lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder as a carrier component, in particular, in the case of a spray, It may additionally include a propellant such as chlorofluorohydrocarbon, propane/butane or dimethyl ether, but may not be limited thereto.
일 실시예에 있어서, 상기 화장료 조성물의 제형이 유연화장수 등의 용액 또는 유탁액인 경우, 담체 성분으로서 용매, 용해화제 또는 유탁화제를 포함할 수 있고, 예를 들어, 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르를 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, when the formulation of the cosmetic composition is a solution or emulsion such as softening lotion, it may contain a solvent, a solubilizing agent or an emulsifying agent as a carrier component, for example, water, ethanol, isopropanol, ethyl Carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan may be included, but may not be limited thereto.
일 실시예에 있어서, 상기 화장료 조성물의 제형이 앰플 등의 현탁액인 경우, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등을 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, when the formulation of the cosmetic composition is a suspension such as an ampoule, water, a liquid diluent such as ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene as carrier components Suspending agents such as sorbitan esters, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be included, but may not be limited thereto.
일 실시예에 있어서, 상기 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우, 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등을 포함할 수 있으나, 이에 제한되지 않을 수 있다.In one embodiment, when the formulation of the cosmetic composition is surfactant-containing cleansing, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate , sarcosinates, fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters, but may not be limited thereto. there is.
이하, 구체적인 실시예와 비교예를 통하여 본 발명의 구성 및 그에 따른 효과를 보다 상세히 설명하고자 한다. 그러나, 본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the configuration of the present invention and its effects will be described in more detail through specific examples and comparative examples. However, these examples are for explaining the present invention in more detail, and the scope of the present invention is not limited to these examples.
[실시예 1][Example 1]
하기 표 1에 기재된 구성성분을 유화기를 이용하여 균일하게 혼합함으로써 앰플 제형의 피부 미백용 화장료 조성물을 제조하고, 이를 실시예 1로 명명하였다.A cosmetic composition for skin whitening in an ampoule formulation was prepared by uniformly mixing the components listed in Table 1 using an emulsifier, and was named Example 1.
[실시예 2][Example 2]
하기 표 2에 기재된 구성성분을 유화기를 이용하여 균일하게 혼합함으로써 크림 제형의 피부 미백용 화장료 조성물을 제조하고, 이를 실시예 2로 명명하였다.A cosmetic composition for skin whitening in a cream formulation was prepared by uniformly mixing the components listed in Table 2 using an emulsifier, and was named Example 2.
[실시예 3 및 실시예 4][Example 3 and Example 4]
하기 표 3에 기재된 구성성분을 유화기를 이용하여 균일하게 혼합함으로써 앰플 제형의 피부 미백용 화장료 조성물을 제조하고, 이를 각각 실시예 3 및 실시예 4로 명명하였다.The components listed in Table 3 were uniformly mixed using an emulsifier to prepare ampoule-type cosmetic compositions for skin whitening, which were named Examples 3 and 4, respectively.
[비교예][Comparative Example]
하기 표 4에 기재된 구성성분을 유화기를 이용하여 균일하게 혼합하여 앰플 형태의 피부 미백용 화장료 조성물을 제조하고, 이를 비교예로 명명하였다.The components listed in Table 4 were uniformly mixed using an emulsifier to prepare a cosmetic composition for skin whitening in the form of an ampoule, which was named a comparative example.
[실험예 1: 피부 미백 효과 측정(in vivo)][Experimental Example 1: Skin whitening effect measurement (in vivo)]
상기 실시예 및 비교예에서 수득된 피부 미백용 화장료 조성물의 미백 효과를 임상 실험을 통해 확인하였다. 실험은 선발 기준에 부합하고 면제 기준에 포함되지 않은 멜라닌과다증 23 명을 대상으로 하였으며, 1 일 2 회 자가 도포 방법으로 적용하였다. 미백 효과는 Mexameter®를 이용한 M-값 (과색소침착증 개선 지수) 평가, 대상별 평가, 피부과 전문의에 의한 피부 자극 평가, 및 피부과 의사의 시각적 평가로 확인하였다.obtained in the above Examples and Comparative Examples The whitening effect of the cosmetic composition for skin whitening was confirmed through clinical trials. The experiment was conducted on 23 hypermelanin patients who met the selection criteria and were not included in the exemption criteria, and applied twice a day as a self-application method. The whitening effect was confirmed by M-value (hyperpigmentation improvement index) evaluation using Mexameter ® , evaluation by subject, skin irritation evaluation by a dermatologist, and visual evaluation by a dermatologist.
도 1은, 상기 피부 미백용 화장료 조성물의 과색소 침착증 개선율은 대조 부위 및 시험 부위의 시험 전 M-값과 시험 후 M-값의 차이를 각각 구하였다. 이를 시험 전 측정치 대비 백분율로 나타내어 개선율을 시간 별로 나타낸 결과이다. 비교예 군과 비교하여, 실시예의 피부 미백용 화장료 조성물은 피부에 적용 후 과색소침착증 개선율이 적용 시간에 따라 유의성 있게 증가하였다. 1, the rate of improvement in hyperpigmentation of the cosmetic composition for skin whitening was obtained by measuring the difference between the M-value before the test and the M-value after the test in the control area and the test area. This is the result of expressing the improvement rate by time by expressing it as a percentage compared to the measured value before the test. Compared to the comparative example group, the cosmetic composition for skin whitening of Example significantly increased the hyperpigmentation improvement rate with application time after application to the skin.
상기 결과는, 본 발명의 피부 미백용 화장료 조성물이 멜라닌 감소 및 이에 따른 피부 미백 효과가 있다는 것을 입증한다.The above results prove that the cosmetic composition for skin whitening of the present invention has a melanin reduction and thus a skin whitening effect.
[실험예 2: 관능평가][Experimental Example 2: Sensory Evaluation]
상기 실시예 및 비교예에서 제조된 피부 미백용 화장료 조성물 각각의 피부 미백, 피부 진정, 피부 보습 유지도, 및 피부 재생 효과를 포함하는 만족도를 평가를 통해 확인하였다. 실험은 선발 기준에 부합하고 면제 기준에 포함되지 않은 만 30 세 내지 45 세의 남녀 90 명을 대상으로 하였으며, 각각 15 명씩으로 나누어 4 주 동안 1 일 1 회, 자가 도포 방법으로 적용한 뒤 전반적인 만족감에 대하여 피험자가 느끼는 기호도를 평가하였다. 평가 기준은 매우 우수하다(5점), 우수하다(4점), 보통이다(3점), 불량하다(2점), 매우 불량하다(1점)로 하였으며, 평균을 계산하여 그 결과를 하기 표 5에 나타내었다.prepared in the above Examples and Comparative Examples Satisfaction including skin whitening, skin soothing, skin moisturizing retention, and skin regeneration effect of each cosmetic composition for skin whitening was confirmed through evaluation. The experiment was conducted on 90 men and women between the ages of 30 and 45 who met the selection criteria and were not included in the exemption criteria. They were divided into 15 people each and applied once a day for 4 weeks as a self-application method. The degree of preference felt by the subject was evaluated. The evaluation criteria were very good (5 points), excellent (4 points), average (3 points), poor (2 points), and very poor (1 point). Table 5 shows.
상기 표 5에 나타낸 바와 같이, 본 발명에 따라 제조된 피부 미백용 화장료 조성물의 경우, 비교예의 화장료 조성물과 달리 피험자의 대부분이 피부 미백, 피부 진정, 피부 보습감, 피부 재생, 및 무자극성 등을 포함하는 전체적인 만족도에 비해 보통 이상으로 평가하였다. As shown in Table 5, in the case of the cosmetic composition for skin whitening prepared according to the present invention, unlike the cosmetic composition of Comparative Example, most of the subjects showed skin whitening, skin soothing, skin moisturizing, skin regeneration, and non-irritation. Overall satisfaction was rated above average.
[실험예 3: 안정성 평가][Experimental Example 3: Stability Evaluation]
상기 실시예 및 비교예에서 제조된 피부 미백용 화장료 조성물들의 안정성 평가를 실시하였다. 안정성 평가는 제조된 화장료 조성물들을 각각 상온(20℃) 및 상온 이상(35℃)에서 3 개월 동안 방치하였을 때 성분의 분리 현상이 나타나는지를 육안으로 판정하였다. 판정 기준은 성분의 분리 현상이 일어난 경우 '불안정', 분리 현상이 일어나지 않은 경우 '안정'으로 기재하였다. 안정성 평가 결과는 하기 표 6에 나타내었다.The stability of the cosmetic compositions for skin whitening prepared in Examples and Comparative Examples was evaluated. In the stability evaluation, it was visually determined whether component separation occurred when the prepared cosmetic compositions were left at room temperature (20° C.) or above room temperature (35° C.) for 3 months, respectively. The criterion was described as 'unstable' when the separation of components occurred, and 'stable' when the separation did not occur. The stability evaluation results are shown in Table 6 below.
상기 표 6에 나타낸 바와 같이, 본 발명에 따른 실시예의 피부 미백용 화장료 조성물은, 35℃의 온도에서 3 개월 동안 방치 시 분리 현상이 일어난 비교예의 화장료 조성물과 달리 상온 및 상온 이상에서 장기 보관 시에도 분리 현상 없이 안정하다는 것을 확인할 수 있었다.As shown in Table 6, the cosmetic composition for skin whitening of Examples according to the present invention, unlike the cosmetic composition of Comparative Example in which separation occurred when left at a temperature of 35 ° C. for 3 months, even when stored for a long time at room temperature or higher than room temperature. It was confirmed that it was stable without any separation phenomenon.
본 명세서에서는 본 발명자들이 수행한 다양한 실시예 가운데 몇 개의 예만을 들어 설명하는 것이나 본 발명의 기술적 사상은 이에 한정하거나 제한되지 않고, 당업자에 의해 변형되어 다양하게 실시될 수 있음은 물론이다.In this specification, only a few examples of various embodiments performed by the present inventors are described, but the technical spirit of the present invention is not limited or limited thereto, and can be modified and implemented in various ways by those skilled in the art, of course.
Claims (8)
글리세린 0.1 내지 10 중량%;
세테아릴올리베이트 0.1 내지 10 중량%;
카프릴릭/카프릭트리글리세라이드 0.1 내지 15 중량%;
솔비탄올리베이트 0.01 내지 5 중량%;
글루타티온 0.000001 내지 0.001 중량%;
카보머 0.01 내지 3 중량%;
토코페릴아세테이트 0.000001 내지 0.001 중량%;
다이소듐이디티에이 0.01 내지 3 중량%;
하이드롤라이즈드호밀피토플라센타추출물 0.000001 내지 0.001 중량%;
표고버섯균사체추출물 0.00001 내지 0.001 중량%;
살비아추출물 0.00001 내지 0.001 중량%;
보골지열매추출물 0.00001 내지 0.001 중량%;
용과 껍질 추출물 0.01 내지 1 중량%;
복령 추출물 0.01 내지 1 중량%; 및
향료 0.01 내지 3 중량%;
를 포함하는, 피부 미백용 화장료 조성물.
75 to 85% by weight of purified water and a solvent including 1,2-hexanediol;
0.1 to 10% by weight of glycerin;
0.1 to 10% by weight of cetearyl olivate;
0.1 to 15% by weight of caprylic/capric triglyceride;
0.01 to 5% by weight of sorbitan olivate;
0.000001 to 0.001% by weight of glutathione;
0.01 to 3% by weight of carbomer;
0.000001 to 0.001% by weight of tocopheryl acetate;
0.01 to 3% by weight of disodium EDTA;
0.000001 to 0.001% by weight of hydrolyzed rye phytoplacenta extract;
Shiitake mushroom mycelium extract 0.00001 to 0.001% by weight;
Salvia extract 0.00001 to 0.001% by weight;
Bogolji fruit extract 0.00001 to 0.001% by weight;
Dragon fruit peel extract 0.01 to 1% by weight;
Bokryeong extract 0.01 to 1% by weight; and
0.01 to 3% by weight of perfume;
Containing, a cosmetic composition for skin whitening.
피부컨디셔닝제, 색소, 및 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상의 첨가제를 추가로 포함하는 것을 특징으로 하는, 피부 미백용 화장료 조성물.
According to claim 1,
A cosmetic composition for skin whitening, further comprising one or more additives selected from the group consisting of skin conditioning agents, pigments, and combinations thereof.
부틸렌글라이콜, 나이아신아마이드, 티아민에이치씨엘, 피리독신, 바이오틴, 사이아노코발아민, 리보플라빈, 폴릭애씨드, 메나다이온, 바이오플라보노이드, 아스코빅애씨드, 판테놀, 트라넥사믹애씨드, 에틸헥실글리세린, 이들의 조합들로 이루어진 군으로부터 선택되는 하나 이상을 포함하는 것을 특징으로 하는, 피부 미백용 화장료 조성물.
The method of claim 3, wherein the skin conditioning agent,
Butylene Glycol, Niacinamide, Thiamine HCL, Pyridoxine, Biotin, Cyanocobalamin, Riboflavin, Polic Acid, Menadione, Bioflavonoids, Ascorbic Acid, Panthenol, Tranexamic Acid, Ethylhexylglycerin, These Characterized in that it comprises at least one selected from the group consisting of combinations, a cosmetic composition for skin whitening.
유연화장수, 크림, 앰플, 젤, 클렌징폼, 팩, 스프레이, 파우더, 및 이들의 조합들로 이루어진 군으로부터 선택된 하나 이상으로 제형화된, 피부 미백용 화장료 조성물.According to any one of claims 1, 3 or 4,
A cosmetic composition for skin whitening formulated with at least one selected from the group consisting of softening lotion, cream, ampoule, gel, cleansing foam, pack, spray, powder, and combinations thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230038444A KR102543302B1 (en) | 2023-03-24 | 2023-03-24 | Cosmetic composition for skin whitening and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230038444A KR102543302B1 (en) | 2023-03-24 | 2023-03-24 | Cosmetic composition for skin whitening and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102543302B1 true KR102543302B1 (en) | 2023-06-15 |
Family
ID=86763603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230038444A KR102543302B1 (en) | 2023-03-24 | 2023-03-24 | Cosmetic composition for skin whitening and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102543302B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102686874B1 (en) * | 2024-03-15 | 2024-07-22 | (주) 라이프위드코퍼레이션 | Cosmetic composition containing five whitening active ingredients and manufacturing method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07187988A (en) * | 1993-12-27 | 1995-07-25 | Nagase & Co Ltd | Melanism inhibitor, its production and skin-beautifying containing the same cosmetic |
KR20000007648A (en) | 1998-07-06 | 2000-02-07 | 서경배 | Cyclooxygenase-2 obstruction containing psoralea corylifolia extracts/or bakuchiol as effective component and anti-inflammation cosmetic material containing psoralea corylifolia extracts/or bakuchiol |
KR20120078327A (en) * | 2010-12-31 | 2012-07-10 | 주식회사한국신약 | Moisturizing and/or whitening cosmetic composition comprising polysaccharide extracted from lentinus edodes mycelium culture product |
KR102370225B1 (en) * | 2021-10-15 | 2022-03-04 | 주식회사 엔에스엘 | Cream type cosmetic composition containing bakuchiol and preparing method thereof |
-
2023
- 2023-03-24 KR KR1020230038444A patent/KR102543302B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07187988A (en) * | 1993-12-27 | 1995-07-25 | Nagase & Co Ltd | Melanism inhibitor, its production and skin-beautifying containing the same cosmetic |
KR20000007648A (en) | 1998-07-06 | 2000-02-07 | 서경배 | Cyclooxygenase-2 obstruction containing psoralea corylifolia extracts/or bakuchiol as effective component and anti-inflammation cosmetic material containing psoralea corylifolia extracts/or bakuchiol |
KR20120078327A (en) * | 2010-12-31 | 2012-07-10 | 주식회사한국신약 | Moisturizing and/or whitening cosmetic composition comprising polysaccharide extracted from lentinus edodes mycelium culture product |
KR102370225B1 (en) * | 2021-10-15 | 2022-03-04 | 주식회사 엔에스엘 | Cream type cosmetic composition containing bakuchiol and preparing method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102686874B1 (en) * | 2024-03-15 | 2024-07-22 | (주) 라이프위드코퍼레이션 | Cosmetic composition containing five whitening active ingredients and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101914157B1 (en) | Cosmetic composition comprising camellia sinensis constituents | |
ES2701598T3 (en) | Use of natural active substances in cosmetic or therapeutic compositions | |
KR102265730B1 (en) | cosmetic composition for skin wrinkle improvement and whitening facial skin | |
JP2002193738A (en) | Use of at least one extract from at least one azalea plant in composition for treating symptom of skin aging | |
KR100767974B1 (en) | A cosmetic composition for reducing the skin pore containing arctium lappa extracts and cold materials | |
ES2697773T3 (en) | Cosmetic and / or dermatological use of a leaf extract of Hamamelis virginiana | |
KR102381273B1 (en) | Cosmetic composition with promoting collagen synthesis and shirinking skin-pores, and Manufacturing method thereof | |
CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
JP2023052050A (en) | Use of nephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes | |
KR102499608B1 (en) | Rejuvenating serum type cosmetic composition and manufacturing method thereof | |
KR20130028548A (en) | Cosmetic composition for skin cell regeneration, anti-inflammation and skin calming effect, and preparing method thereof | |
KR102476660B1 (en) | Cosmetic composition for skin improvement containing vitamin and natural extracts | |
KR102181279B1 (en) | Cosmetic composition for skin aging prevention, wrinkle improvement, flexibility enhancement, and elasticity improvement | |
KR102543302B1 (en) | Cosmetic composition for skin whitening and manufacturing method thereof | |
KR102445830B1 (en) | Cosmetic Compositions for Skin Moisture Comprising Extract of Triticum aestivum | |
KR101744889B1 (en) | Composition for Anti-oxidation, Whitening and Wrinkles protection | |
KR102184317B1 (en) | A complex materials for antiwrinkle and skin whitening | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR101203504B1 (en) | Composition for Wrinkle-Care or Skin Whitening Containing Fermentation Liquor of Extract from Stewartia koreana | |
KR101854444B1 (en) | A cosmetic composition for the prevention and improvement of striae distensae containing a extract of cynara scolymus | |
KR102107193B1 (en) | Cosmetic composition comprising extract of calendula arvensis fermented by aureobasidium pullulans | |
KR102018512B1 (en) | Cosmetic composition comprising extract of saliva miltiorrhiza fermented by aureobasidium pullulans | |
KR101427027B1 (en) | A Skin External Composition Containing Callus Extract Derived from Chaenomeles Sinensis | |
RU2242216C1 (en) | Lifting-cream for dry and sensitive skin | |
JP2018516878A (en) | Gentian extract without gentiopicroside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |